1 Veillat V,Sengers V,Metz CN,et al.Macrophage migration inhibitory factor is involved in a positive feedback loop increasing aromatase expression in endometriosis.Am J Pathol,2012,181:917-927.
2 Yang H,Lang JH,Zhu L,et al.Diagnostic value of the neutrophiltolymphocyte ratio and the combination of serum CA-125 for stages Ⅲ and Ⅳ endometriosis.Chin Med J (Engl),2013,126:2011-2014.
3 Xu H,Zhang T,Man GC,et al.Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions,vascular permeability and angiogenesis and growth of endometriosis.Angiogenesis,2013,16:541-551.
4 俞丹华.巨噬细胞移动抑制因子、血管生成素-2、血管内皮生长因子在子宫内膜异位症中的意义.临床和实验医学杂志,2015,14:101-103.
5 王菲,崔宏伟.子宫内膜异位症患者血清和腹腔液CA-125抗原、血管内皮生长因子水平的相关性研究.中国医师进修杂志,2015,38:664-667.
6 Stilley JA,Birt JA,Sharpe-Timms KL.Cellular and molecular basis for endometriosis-associated infertility.Cell Tissue Res,2012,349:849-862.
7 Mei J,Xie XX,Li MQ,et al.Indoleamine 2,3-dioxygenase-1 (IDO1) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosis.Int J Clin Exp Pathol,2014,7:2743-2757.
8 Pan X,Mao X,Cheng T,et al.Macrophage migrationinhibitiory factor:a regular of MMP13 and inflammation in titanium particles stimulated air pouch in vivo.Mol Cell Biochem,2011,357:313-321.
9 杨剑,陈景伟,赵静,等.子宫内膜异位症患者腹腔液中血管内皮生长因子、卵巢癌抗原水平的变化及临床意义.解放军医药杂志,2012,24:14-17.
10 Li YZ,Wang LJ,Li X,et al.Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis:an updated systematic review and meta-analysis of 14 case-control studies.Genet Mol Res,2013,12:1035-1044.
11 陆丹,贺青蓉,秦炜,等.组织因子和血管内皮生长因子在子宫内膜异位症组织中的表达及意义.广东医学,2015,36:1863-1865.
